Neurobiological alteration in agitation in Alzheimer's disease and possible interventions

被引：1
|
作者：
Rao, Jagadeesh S. [1 ]
Tangarife, Maria Alejandra [1 ]
Mukunda, Ram [1 ]
机构：
[1] India Globalizat Capital IGC Pharm, Sci Dept, Potomac, MD 20859 USA
来源：
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词：
agitation; Alzheimer's disease; neuroinflammation; GABA; CBR-1; THC; melatonin; SYMPTOMS; DRONABINOL; CORTEX; GABA;
D O I：
10.3389/fpsyt.2024.1412901
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Quetiapine in the treatment of agitation in patients with Alzheimer's disease
    Zhong, K
    Tariot, P
    Minkwitz, M
    Devine, N
    Mintzer, J
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 325 - 326
  • [32] An update on the advancements in the treatment of agitation in Alzheimer's disease
    Porsteinsson, Anton P.
    Antonsdottir, Inga M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (06) : 611 - 620
  • [33] Risk factors for agitation in patients with Alzheimer's disease
    Auchus, AP
    Woodard, JL
    Simpson, SR
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (09) : P192 - P192
  • [34] Prazosin for treatment of disruptive agitation in Alzheimer's disease
    Wang, Lucy Y.
    Petrie, Eric C.
    Rohde, Kirsten
    Hart, Kim L.
    Hoff, David J.
    Shofer, Jane B.
    Raskind, Murray A.
    Peskind, Elaine R.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 200S - 200S
  • [35] Therapeutic touch and agitation in individuals with Alzheimer's disease
    Hawranik, Pamela
    Johnston, Pat
    Deatrich, Judith
    WESTERN JOURNAL OF NURSING RESEARCH, 2008, 30 (04) : 417 - 434
  • [36] Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation
    Oguma, Takuya
    Jino, Kohei
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (07) : 610 - 617
  • [37] Commentary on "low use of analgesics in Alzheimer's disease: Possible mechanisms" - Memory, pain, agitation, and dissociation
    Chefetz, RA
    PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2000, 63 (01): : 18 - 22
  • [38] Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease
    Pantiya, Patcharapong
    Thonusin, Chanisa
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    MITOCHONDRION, 2020, 55 : 14 - 47
  • [39] Interventions for Alzheimer's disease.
    McShane, JA
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 13 (09) : 650 - 650
  • [40] Nonpharmacological Interventions for Alzheimer's Disease
    Lee, Seok Bum
    Kim, Ki Woong
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (11): : 1069 - 1076
12345